Understanding Perspective Therapeutics Inc (CATX)’s Gross Margin and Net Margin Figures

A share price of Perspective Therapeutics Inc [CATX] is currently trading at $1.64, up 3.80%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CATX shares have gain 7.19% over the last week, with a monthly amount glided 37.82%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Perspective Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.20 and $1.77. Perspective Therapeutics Inc [AMEX: CATX] shares were valued at $1.64 at the most recent close of the market.

Analyzing the CATX fundamentals

Trailing Twelve Months sales for Perspective Therapeutics Inc [AMEX:CATX] were 8.84M which represents 27.26% growth. Gross Profit Margin for this corporation currently stands at 0.11% with Operating Profit Margin at -5.13%, Pretax Profit Margin comes in at -4.94%, and Net Profit Margin reading is -3.4%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.25 and Total Capital is -0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5867 points at the first support level, and at 1.5333 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6967, and for the 2nd resistance point, it is at 1.7533.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Perspective Therapeutics Inc [AMEX:CATX] is 2.67. In addition, the Quick Ratio stands at 2.55 and the Cash Ratio stands at 2.22. Considering the valuation of this stock, the price to sales ratio is 108.89, the price to book ratio is 4.66.

Transactions by insiders

Recent insider trading involved Lantheus Alpha Therapy, LLC, 10% Owner, that happened on Mar 06 ’24 when 60.43 million shares were purchased. Director, Williamson Robert F III completed a deal on Jan 30 ’24 to buy 0.13 million shares. Meanwhile, Director Williamson Robert F III bought 25266.0 shares on Jan 29 ’24.

Related Posts